Moderate to Severe Atopic Dermatitis: Targeted Pathways and Strategies to Personalize Patient Care

Gain expert insights on personalizing care for patients with moderate to severe AD, including choosing among current treatment options, understanding emerging therapies, and recommending vaccinations for patients receiving immunosuppressants and immunomodulatory therapies for AD.
Sarah Lant, PharmD
Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES
Format: Microsoft PowerPoint (.ppt)
File Size: 4.94 MB
Released: May 18, 2022

Acknowledgements

Provided by ProCE, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Incyte Corporation

Related Content

Dr Geoffrey C. Wall discusses how updated guidelines inform the selection of appropriate therapy for patients with severe asthma, from ProCE

Geoffrey C. Wall, PharmD, FCCP, BCPS Released: June 7, 2022

Dr Jamie McConaha discusses the current understanding of atopic dermatitis pathophysiology and the latest biologic therapies used for treatment, from ProCE

Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES Released: June 1, 2022

Slideset with expert insights on the optimal management of severe asthma to improve clinical and economic outcomes from ProCE.

Suzanne G. Bollmeier, PharmD, FCCP, BCPS, AE-C Geoffrey C. Wall, PharmD, FCCP, BCPS Released: May 17, 2022

Downloadable slides featuring expert insight on obesity, including guideline recommendations and a review of available pharmacotherapy, from ProCE

Released: April 12, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings